Profile of judicialization in access to antineoplastic drugs and their costs: A cross-sectional, descriptive study based on a set of all lawsuits fled between 2016 and 2018 in a state in the Northeast Region of Brazil

The judicialization of the acquisition of medication for healthcare is not restricted to Brazil but can also be found in other Latin American countries, despite the existence of a universal health system in the case of Brazil, the Unified Health System (known as the SUS).